About Insulet

     

We were founded for a single reason:
to improve the lives of people with diabetes.

 

In 1992 a young boy was diagnosed with diabetes. His father, hunting for the best possible treatment, did exhaustive research. He found that insulin pump therapy offered dramatically better control than injections, with far less risk of long-term complications.1 Plus his son could eat and exercise freely with an insulin pump. But all that tubing seemed like such a burden for a young boy—and where would the pump go during swimming lessons? The father thought there had to be a better way.

 

He gathered the best diabetes and technology experts he could find, and in July, 2000, we formed a company, Insulet Corporation, to improve the traditional insulin pump. Together we got input from people on insulin pumps, people taking insulin injections and healthcare providers across the country. And we created the OmniPod System, a completely unique approach offering all the benefits of insulin pump therapy, with none of the issues.

 

Of course, our work is not done. We will continue to push our own research. We will continue to harness medical, scientific and technological advances. We will continue to hone the OmniPod System. Because ultimately, our goal is to provide superior treatment options for people with diabetes—and to make diabetes an ever smaller part of life.


1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine.1993:329:977-986.